The company said it plans to secure additional critical patient beds, while also trying to secure intensive care units by bringing

The company said it plans to secure additional critical patient beds, 강남가라오케 while also trying to secure intensive care units by bringing all patients who have improved depending on their condition. SK Bioscience announced on the 24th that it has received approval from the Ministry of Food and Drug Safety for the clinical 강남야구장 first phase test plan of Corona 19 vaccine candidate "NBP2001." The first phase of NBP2001 clinical trial will be conducted on 50 healthy adults at Seoul National University Hospital and Bundang Seoul National University Hospital to assess their safety and immunity. SK Bioscience expects that NBP2001 will be advantageous in securing safety in that it is a synthetic antigen vaccine that has been stabilized 강남룸싸롱 through protein culture and refining.